“It is hard to work with patients for very long without wanting to do more, to help more people, to find answers to the problems that people with diabetes face.”
—ANNE PETERS, MD
Research and Advocacy
We work on several fronts to change the future of diabetes care, from testing innovative medications and devices to developing preventive strategies that stop diabetes from developing.
Backed by the National Institutes of Health (NIH), we are a study site on the benefits of Vitamin D on diabetes prevention. In addition, we are in our 12th year in the LookAHEAD study, an Intensive Lifestyle Intervention focused on weight loss achieved through healthy eating and increased physical activity in overweight and obese individuals with type 2 diabetes. We have been able to contrubute contribute to these major national studies by enrolling residents from the Latino resident population we serve at Roybal Comprehensive Health Center in East Los Angeles.
Access Other studies give our patients early access to new solutions. These include the T1D Exchange Network, which is testing a closed-loop insulin delivery system, along with clinical trials that are analyzing a continuous glucose monitor (CGM) in seniors and in family members without diabetes. We are one of the first centers to test the new Dexcom G6 CGM sensor, and we’re part of TrialNet, an international network exploring how type 1 diabetes can be prevented. We are also currently conducting a study on a potentially better way of using inhaled and a study using a closed-loop CGM/insulin pump system is scheduled for next year.
Advocacy Dr. Peters is leading an effort to change the Centers for Medicare & Medicaid Services (CMS) policy for insulin pump approval for seniors and has lobbied to convince CMS to fund CGMs for seniors and people with Medicaid.
Prevention We are committed to studying how lifestyle approaches — diet, exercise and weight loss — may improve long-term health outcomes. Our team conducts on-the-ground research to help whole neighborhoods become healthier, including establishing and studying the impact of farmer’s markets.
CONCLUSIONS: Use of CGM without regular use of confirmatory BGM is as safe and effective as using CGM with BGM in well-controlled adults with T1D at low risk for severe hypoglycemia.
CONCLUSION: Future studies need to focus on how to prevent hypoglycemia in this vulnerable population of older adults with long-standing T1D.
This Review provides an up-to-date consensus on exercise management for individuals with type 1 diabetes who exercise regularly, including glucose targets for safe and effective exercise, and nutritional and insulin dose adjustments to protect against exercise-related glucose excursions.